![Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded,](https://www.thelancet.com/cms/asset/b3644d44-8ece-4890-a69d-0d99b28fd20d/gr1a.jpg)
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded,
![Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial - The Lancet Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial - The Lancet](https://www.thelancet.com/cms/asset/1ca592be-4bb8-4fb1-a5ea-f55f3f7a73a3/gr1.jpg)
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial - The Lancet
![Nationwide tuberculosis outbreak in the USA linked to a bone graft product: an outbreak report - The Lancet Infectious Diseases Nationwide tuberculosis outbreak in the USA linked to a bone graft product: an outbreak report - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/1dde4a00-35d3-4b9c-9788-68fe67470fed/gr1.jpg)
Nationwide tuberculosis outbreak in the USA linked to a bone graft product: an outbreak report - The Lancet Infectious Diseases
![Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study - The Lancet Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study - The Lancet](https://www.thelancet.com/cms/asset/3ab1205f-8a1c-457c-87bf-1713210516a3/gr1.jpg)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study - The Lancet
![Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology](https://www.thelancet.com/cms/asset/c709a625-668f-411d-ba24-4c875e24aefa/gr1a.jpg)
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology
![Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet](https://www.thelancet.com/cms/attachment/43c19cc3-58f4-41c4-8c50-86f1f443c0fb/gr1.jpg)
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet
![Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet](https://www.thelancet.com/cms/asset/010fc55e-684e-416e-9c4e-839b914722d9/gr1.jpg)
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet
![Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Gastroenterology & Hepatology Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/84236420-be98-4abe-814f-eb61f6a6aab8/gr1.jpg)
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Gastroenterology & Hepatology
Five Glutathione S-Transferase Gene Variants in 23,452 Cases of Lung Cancer and 30,397 Controls: Meta-Analysis of 130 Studies | PLOS Medicine
![Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 | MMWR Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 | MMWR](https://www.cdc.gov/mmwr/volumes/69/wr/social-media/mm6915e3_HospitalizationsCOVID19_IMAGE_08April20_1200x675.jpg)
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 | MMWR
![Majority in U.S. Says Public Health Benefits of COVID-19 Restrictions Worth the Costs, Even as Large Shares Also See Downsides | Pew Research Center Majority in U.S. Says Public Health Benefits of COVID-19 Restrictions Worth the Costs, Even as Large Shares Also See Downsides | Pew Research Center](https://www.pewresearch.org/science/wp-content/uploads/sites/16/2021/09/PS_2021.09.15_covid19-restrictions_00-01.png?w=420)
Majority in U.S. Says Public Health Benefits of COVID-19 Restrictions Worth the Costs, Even as Large Shares Also See Downsides | Pew Research Center
![Fact Sheet: Weakening Requirements to Carry a Concealed Firearm Increases Violent Crime - Center for American Progress Fact Sheet: Weakening Requirements to Carry a Concealed Firearm Increases Violent Crime - Center for American Progress](https://www.americanprogress.org/wp-content/uploads/2022/09/handguncropped.jpg?w=1680)